GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,429.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.93m
  • Volume: 8,105,348
  • Market Cap: £58,517m
  • RiskGrade: 129

Key dates

Dividend  
Latest XD Date (Q4) 23-Feb-2023
Latest Pay Date (Q4) 13-Apr-2023
   
Meetings  
AGM 03-May-2023
EGM n/a
GMs 06-Jul-2022
   
Announcements  
Trading announcement 24-Jul-2009
IMSs 26-Jul-2011
Drilling Report n/a
   
Results  
Final results 01-Dec-2023
Interim results 27-Jul-2022
Q1 Results 27-Apr-2022
Q2 Results 27-Jul-2022
Q3 Results 02-Nov-2022
Q4 Results 01-Feb-2023
Annual Report 10-Mar-2023
   
Year End 31-Dec-2023

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 1,429.00p
Change Today 9.00p
% Change 0.63 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 8,105,348
Shares Issued 4,094.93m
Market Cap £58,517m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.66% below the market average69.66% below the market average69.66% below the market average69.66% below the market average69.66% below the market average
5.08% above the sector average5.08% above the sector average5.08% above the sector average5.08% above the sector average5.08% above the sector average
Price Trend
8.71% below the market average8.71% below the market average8.71% below the market average8.71% below the market average8.71% below the market average
46.03% above the sector average46.03% above the sector average46.03% above the sector average46.03% above the sector average46.03% above the sector average
Income
38.53% above the market average38.53% above the market average38.53% above the market average38.53% above the market average38.53% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Growth
52.17% below the market average52.17% below the market average52.17% below the market average52.17% below the market average52.17% below the market average
52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average

What The Brokers Say

Strong Buy 3
Buy 6
Neutral 13
Sell 1
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-23 17-Nov-22
Paid 13-Apr-23 12-Jan-23
Amount 13.75p 13.75p

Trades for 31-Mar-2023

Time Volume / Share Price
17:39 9,786 @ 1,432.28p
17:39 13,639 @ 1,432.26p
17:39 13,947 @ 1,428.99p
17:39 15,224 @ 1,428.99p
17:39 18,335 @ 1,431.99p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page